Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Verrica Pharmaceuticals Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
CP
Caligan Partners LP
13D · 10.0%
|
923.9K | 4.34% | Unchanged | 2024 | 0.3% | |
|
Shares held by quarter
Peak holding9.2M (Q2'25)
Change over 8 quarters+923.9K
Share of the company4.340%
Disclosed stake13D · 10.0%
|
||||||
|
CC
Cannell Capital LLC
|
783.9K | 3.68% | +98.8K (+14.4%) | Q1 '26 | 3.2% | |
|
Shares held by quarter
Peak holding783.9K (Q2'26)
Change over 8 quarters+783.9K
Share of the company3.680%
|
||||||
28 more super investors behind a free account
See every manager holding Verrica Pharmaceuticals Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$876K | 143.1K | 0.67% | 0.00% | June 30, 2026 |
|
VE
Vanguard Index Funds
|
$829K | 135.5K | 0.64% | 0.00% | June 30, 2026 |
17 more funds behind a free account
See every fund holding Verrica Pharmaceuticals Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
PB
Paul B Manning
5%+ holder
13D · 49.9%
|
8.1M | 37.81% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
DJ
David Johnson
5%+ holder
13D · 10.0%
|
6.5M | 30.52% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
7 more holders behind a free account
See every insider and 5%+ holder of Verrica Pharmaceuticals Inc..
Sign up freeLoading...